Watermark
  Back to Search Results

BGB-3111-112

Completed

The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-112

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04470908

Study Overview

Sex: Male Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 65 Years

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: Male Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 65 Years

Study Documents

Study Protocol Statistical Analysis Plan